Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

Media Advisory - Prime Minister's itinerary for Wednesday, July 8, 2020


OTTAWA, ON, July 7, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario



Private meetings.



11:00 a.m.

The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow.




Room 225


West Block


Parliament Hill




Notes for media:




  • Open coverage
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Journalists can dial in to listen and ask questions to the Prime Minister.
  • Participant dial-in numbers:
    Local: 613-954-9003
    Toll-free: 1-866-206-0153
    Pass code: 6822783#


12:00 p.m. 

The Prime Minister will attend the sitting of the House of Commons.

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 04:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it has surpassed 55 million miles driven across its range of products.Phoenix offers a range of...

at 03:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced the appointment of Michael Yung as its new Chief Financial Officer (CFO), effective April 17,...

at 02:00
Centamin plc ("Centamin", "Group" or "the Company") (LSE:CEY)QUARTERLY REPORTfor the three months ended 31 March 2024MARTIN HORGAN, CEO, commented: "The scheduled processing of lower-grade ore from the open pit,...

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...

at 01:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...



News published on and distributed by: